Skip to main content
. 2019 Oct 3;10:4493. doi: 10.1038/s41467-019-12366-4

Table 1.

Demographics of study subjects

Schizophrenia patients (n = 19) (mean ± SEM) Controls (n = 20) p-value
Age (years) 35.1 ± 2.1 36.85 ± 2.7 0.61
Gender (male/female) 19/0 18/2 0.256
Injected radioactivity (MBq) 198.6 ± 9.1 198.5 ± 9.7 0.9
Injected mass per body weight (µgm/kg) 0.023 ± 0.003 0.024 ± 0.003 0.6
BMI (kg/m2) 29.3 ± 1 25.2 ± 0.8 0.003*
Mean age at onset (years) 23.05 ± 1.2 n/a n/a
Mean duration of illness (years) 11.3 ± 2.2 n/a n/a
PANSS n/a n/a
 Positive 14.5 ± 0.4
 Negative 21.4 ± 1
 General 26.5 ± 0.8
 Total 62.5 ± 1.9
SANS-25 55.7 ± 5 n/a n/a
Revised social anhedonia scale 17.6 ± 1.9 9.8 ± 1.7 0.004*
Revised physical anhedonia scale 23.3 ± 2.8 13.3 ± 3 0.017*
Temporal experience pleasure scale
 Anticipatory pleasure scale 38.9 ± 2.6 43.2 ± 2 0.2
 Consummatory pleasure scale 28.3 ± 2.3 35 ± 1.7 0.025*
Genotyping rs1799971-
  A:A 16 15 0.9
  G:A 3 4
  G:G 0 1
Calgary depression scale total score 7.7 ± 1.5 n/a n/a
Number of cigarette smoked per day 8.2 ± 2.1 0.9 ± 0.6 0.001*

There were no significant differences in demographics other than for body mass index (BMI) and number of cigarettes smoked per day

n/a not applicable; *p < 0.05